224 related articles for article (PubMed ID: 16914575)
1. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
Miyata Y; Kanetake H; Kanda S
Clin Cancer Res; 2006 Aug; 12(16):4876-81. PubMed ID: 16914575
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
3. TFE3-renal carcinoma in an adult patient: a case with strong expression of phosphorylated hepatocyte growth factor (HGFR)/Met.
Sagara Y; Miyata Y; Nomata K; Abe K; Eguchi J; Hayashi T; Sakai H; Kanda S; Kanetake H
Pathol Res Pract; 2009; 205(1):57-61. PubMed ID: 18930356
[TBL] [Abstract][Full Text] [Related]
4. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
Shi BB; Zhang XH; Wang HJ; Li HZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.
Betsunoh H; Mukai S; Akiyama Y; Fukushima T; Minamiguchi N; Hasui Y; Osada Y; Kataoka H
Cancer Sci; 2007 Apr; 98(4):491-8. PubMed ID: 17309599
[TBL] [Abstract][Full Text] [Related]
6. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
Lashkari K; Rahimi N; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
10. Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells.
Liu SI; Lui WY; Mok KT; Wu CW; Chi CW
Anticancer Res; 1997; 17(5A):3575-80. PubMed ID: 9413205
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
[TBL] [Abstract][Full Text] [Related]
14. Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma.
Matsuo T; Miyata Y; Watanabe S; Ohba K; Hayashi T; Kanda S; Sakai H
Urology; 2011 Aug; 78(2):476.e9-15. PubMed ID: 21696810
[TBL] [Abstract][Full Text] [Related]
15. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
Herynk MH; Stoeltzing O; Reinmuth N; Parikh NU; Abounader R; Laterra J; Radinsky R; Ellis LM; Gallick GE
Cancer Res; 2003 Jun; 63(11):2990-6. PubMed ID: 12782608
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
18. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
20. C-jun activation in acquired cystic kidney disease and renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Marumo K; Mukai M; Murai M
J Urol; 2005 Aug; 174(2):726. PubMed ID: 16006965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]